Nebraska Statutes
§ 71-9602 — Terms, defined
Nebraska·Ch. 71 Public Health and Welfare
For purposes of the Investigational Drug Use Act:
(1)Advanced illness means any progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of federally approved and available treatments, and that, without life-sustaining procedures, would likely result in death within six months;
(2)Eligible patient means a person who meets the requirements of section 71-9603 ;
(3)Health care provider has the same meaning as in section 71-7907 ;
(4)Investigational drug, biological product, or device means any drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States
Free access — add to your briefcase to read the full text and ask questions with AI
Nebraska § 71-9602 (Terms, defined) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
Source: Laws 2018, LB117, § 2.
Cross References: Medicine and Surgery Practice Act, see section 38-2001.
Nearby Sections
15
§ 71-1002
Repealed. Laws 2019, LB559, § 6§ 71-1005
Repealed. Laws 2019, LB559, § 6§ 71-1006
Repealed. Laws 2019, LB559, § 6§ 71-1007
Board; purpose§ 71-101
Transferred to section38-101§ 71-101.01
Repealed. Laws 2007, LB 463, § 1319§ 71-101.02
Repealed. Laws 1988, LB 1100, § 185§ 71-102
Transferred to section38-121§ 71-103
Transferred to section38-129§ 71-104.01
Transferred to section38-131§ 71-105
Transferred to section38-122